H.R. 653: Protect Minors from Medical Malpractice Act of 2025
This bill, titled the Protect Minors from Medical Malpractice Act of 2025, is designed to address medical procedures related to gender transition for individuals under the age of 18. Below is a summary of its main provisions:
Private Right of Action
- Medical practitioners performing gender-transition procedures on minors can be held liable if the individual experiences any form of harm, including physical, psychological, emotional, or physiological injuries.
- Minors and their representatives can file lawsuits against these practitioners within 30 years after the individual turns 18. The lawsuits may seek:
- Declaratory or injunctive relief
- Compensatory damages
- Punitive damages
- Attorney's fees and costs
Circumstances for Liability
Liability applies when any of the following conditions are met:
- The medical procedures involved interstate or foreign commerce.
- The medical practitioner used means of interstate commerce in performing the procedures.
- Any payment related to the procedures was made using interstate commerce.
- Communications about the procedures involved interstate commerce.
- Instruments or materials used in the procedures were obtained through interstate commerce.
- The procedures took place in specific U.S. jurisdictions or territories.
- Overall conduct impacted interstate or foreign commerce.
Freedom of Conscience for Medical Providers
Medical practitioners cannot be mandated by federal law to perform gender-transition procedures, thereby preserving their right to make medical judgments based on personal or professional convictions.
Federal Funding Restrictions for States
States that require medical practitioners to perform any gender-transition procedures will be ineligible to receive federal funding from the Department of Health and Human Services.
Definitions
- Biological Sex: Defined by genetic characteristics and the body's reproductive structure, independent of personal identity.
- Gender-Transition Procedure: Includes:
- Administration of puberty-blocking drugs
- Administration of cross-sex hormones
- Surgical procedures for transitioning
- Exceptions apply for certain medical conditions such as:
- Individuals with ambiguous biological sex characteristics.
- Those with specific genetic or hormonal disorders.
- Conditions posing immediate health risks necessitating intervention.
- Medical Practitioner: Any licensed person authorized to provide healthcare.
Effective Date
The bill would take effect upon enactment.
Relevant Companies
None found
This is an AI-generated summary of the bill text. There may be mistakes.
Sponsors
2 bill sponsors
Actions
2 actions
Date | Action |
---|---|
Jan. 23, 2025 | Introduced in House |
Jan. 23, 2025 | Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, Education and Workforce, Natural Resources, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
Corporate Lobbying
0 companies lobbying
None found.
* Note that there can be significant delays in lobbying disclosures, and our data may be incomplete.
Potentially Relevant Congressional Stock Trades
No relevant congressional stock trades found.